Cargando…
Strategies for modern biomarker and drug development in oncology
Technological advancements in the molecular characterization of cancers have enabled researchers to identify an increasing number of key molecular drivers of cancer progression. These discoveries have led to multiple novel anticancer therapeutics, and clinical benefit in selected patient populations...
Autores principales: | Smith, Alan D, Roda, Desam, Yap, Timothy A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4189730/ https://www.ncbi.nlm.nih.gov/pubmed/25277503 http://dx.doi.org/10.1186/s13045-014-0070-8 |
Ejemplares similares
-
Precision Medicine for Molecularly Targeted Agents and Immunotherapies in Early-Phase Clinical Trials
por: Lopez, Juanita, et al.
Publicado: (2015) -
Modern treatment strategies in pediatric oncology and hematology
por: Adamczewska-Wawrzynowicz, Katarzyna, et al.
Publicado: (2023) -
Clinical pharmacology strategies in supporting drug development and approval of antibody–drug conjugates in oncology
por: Liu, Stephanie N., et al.
Publicado: (2021) -
Seamless Designs: Current Practice and Considerations for Early-Phase Drug Development in Oncology
por: Hobbs, Brian P, et al.
Publicado: (2018) -
A Review of Fish Vaccine Development Strategies: Conventional Methods and Modern Biotechnological Approaches
por: Ma, Jie, et al.
Publicado: (2019)